BioSkryb Genomics

BioSkryb Genomics is a pioneering company in the field of single-cell analysis and genomics. They specialize in understanding cellular heterogeneity and the genomic variability between individual cells, which is crucial for developing precise and effective treatments for diseases like cancer. By utilizing their patented Primary Template-directed Amplification (PTA) and BaseJumper™ bioinformatics platform, BioSkryb enables scientists to gain insights into dynamic molecular information from single cells. Their innovations support scientific discoveries and advancements in genomics, particularly in single-cell multiomic analysis, which integrates the genome and transcriptome amplification from the same cell. BioSkryb Genomics aims to empower research in genomics, single-cell biology, and translational medicine with their cutting-edge technologies and services.